Cargando…

SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma

Background: Insulinoma is a rare, sporadic neuroendocrine tumor, with incidence of 4 cases per million people (1). It is often difficult to diagnose given presentation of vague symptoms and often lack of localization of tumor on initial imaging. Timely diagnosis is usually necessary as there is comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Nushin, Liao, Huijuan, Joutovsky, Alla, Ciancarelli, James, Shapiro, Lawrence, Klek, Stanislaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552960/
http://dx.doi.org/10.1210/js.2019-SUN-315
_version_ 1783424709041324032
author Khan, Nushin
Liao, Huijuan
Joutovsky, Alla
Ciancarelli, James
Shapiro, Lawrence
Klek, Stanislaw
author_facet Khan, Nushin
Liao, Huijuan
Joutovsky, Alla
Ciancarelli, James
Shapiro, Lawrence
Klek, Stanislaw
author_sort Khan, Nushin
collection PubMed
description Background: Insulinoma is a rare, sporadic neuroendocrine tumor, with incidence of 4 cases per million people (1). It is often difficult to diagnose given presentation of vague symptoms and often lack of localization of tumor on initial imaging. Timely diagnosis is usually necessary as there is commonly total resolution with surgery. We present a unique case of ketogenic diet unmasking insulinoma in a young healthy male. Clinical Case: An obese otherwise healthy 47-year male presented to our institution with rapid onset altered mental status followed by syncope and witnessed seizure-like activity. He denied previous episodes, although recalled symptoms of diaphoresis and confusion at night since beginning the ketogenic diet one week prior. Initial evaluation demonstrated normal metabolic panel, thyroid function, cortisol level, and HbA1C value of 4.8%, however plasma glucose level was 30 mg/dL with a corresponding insulin level to 87.9 (2.6-24.9) mlU/mL. Initial trauma protocol CT did not reveal injuries and the pancreas appeared normal. Hypoglycemia resolved initially following dextrose administration, however, he had several repeat episodes of symptomatic hypoglycemia despite continuous IV dextrose infusion and eating an oral diet. Two hours into 72 hour fasting test, he developed symptoms of neuroglycopenia, glucose level of 38 mg/dl with insulin level of 76.6 mlU/mL and C-peptide level of 6.7 ng/mL (1.1-1.4 ng/mL). MRI abdomen revealed 2.2x1.5 cm T2-hyperintense, hypervascular lesion in the pancreatic body with restricted diffusion, compatible with neuroendocrine tumor. Endoscopic ultrasound was completed for surgical planning. Diazoxide was initiated while awaiting surgery. He underwent successful enucleation of solitary pancreatic head lesion with resolution of episodic hypoglycemia. Histopathology confirmed neuroendocrine tumor, immunostaining positive for insulin. Conclusion: While clinicians have used ketogenic diet in aiding patients with epilepsy, the recent trend of this very low carbohydrate, high-fat diet for weight loss has been controversial. Insulinoma can be a diagnostic challenge, given the typical clinical presentation is a prolonged course of vague symptoms. Our case is atypical given the rapid onset of symptoms, diagnosis and appropriate treatment within two weeks of starting ketogenic diet. Reference: (1) Mathur, A, et al. “Insulinoma”. Surg Clin North Am. 89.5. (2009)
format Online
Article
Text
id pubmed-6552960
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65529602019-06-13 SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma Khan, Nushin Liao, Huijuan Joutovsky, Alla Ciancarelli, James Shapiro, Lawrence Klek, Stanislaw J Endocr Soc Tumor Biology Background: Insulinoma is a rare, sporadic neuroendocrine tumor, with incidence of 4 cases per million people (1). It is often difficult to diagnose given presentation of vague symptoms and often lack of localization of tumor on initial imaging. Timely diagnosis is usually necessary as there is commonly total resolution with surgery. We present a unique case of ketogenic diet unmasking insulinoma in a young healthy male. Clinical Case: An obese otherwise healthy 47-year male presented to our institution with rapid onset altered mental status followed by syncope and witnessed seizure-like activity. He denied previous episodes, although recalled symptoms of diaphoresis and confusion at night since beginning the ketogenic diet one week prior. Initial evaluation demonstrated normal metabolic panel, thyroid function, cortisol level, and HbA1C value of 4.8%, however plasma glucose level was 30 mg/dL with a corresponding insulin level to 87.9 (2.6-24.9) mlU/mL. Initial trauma protocol CT did not reveal injuries and the pancreas appeared normal. Hypoglycemia resolved initially following dextrose administration, however, he had several repeat episodes of symptomatic hypoglycemia despite continuous IV dextrose infusion and eating an oral diet. Two hours into 72 hour fasting test, he developed symptoms of neuroglycopenia, glucose level of 38 mg/dl with insulin level of 76.6 mlU/mL and C-peptide level of 6.7 ng/mL (1.1-1.4 ng/mL). MRI abdomen revealed 2.2x1.5 cm T2-hyperintense, hypervascular lesion in the pancreatic body with restricted diffusion, compatible with neuroendocrine tumor. Endoscopic ultrasound was completed for surgical planning. Diazoxide was initiated while awaiting surgery. He underwent successful enucleation of solitary pancreatic head lesion with resolution of episodic hypoglycemia. Histopathology confirmed neuroendocrine tumor, immunostaining positive for insulin. Conclusion: While clinicians have used ketogenic diet in aiding patients with epilepsy, the recent trend of this very low carbohydrate, high-fat diet for weight loss has been controversial. Insulinoma can be a diagnostic challenge, given the typical clinical presentation is a prolonged course of vague symptoms. Our case is atypical given the rapid onset of symptoms, diagnosis and appropriate treatment within two weeks of starting ketogenic diet. Reference: (1) Mathur, A, et al. “Insulinoma”. Surg Clin North Am. 89.5. (2009) Endocrine Society 2019-04-30 /pmc/articles/PMC6552960/ http://dx.doi.org/10.1210/js.2019-SUN-315 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Tumor Biology
Khan, Nushin
Liao, Huijuan
Joutovsky, Alla
Ciancarelli, James
Shapiro, Lawrence
Klek, Stanislaw
SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma
title SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma
title_full SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma
title_fullStr SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma
title_full_unstemmed SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma
title_short SUN-315 Ketogenic Diet Unmasking a Case of Insulinoma
title_sort sun-315 ketogenic diet unmasking a case of insulinoma
topic Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552960/
http://dx.doi.org/10.1210/js.2019-SUN-315
work_keys_str_mv AT khannushin sun315ketogenicdietunmaskingacaseofinsulinoma
AT liaohuijuan sun315ketogenicdietunmaskingacaseofinsulinoma
AT joutovskyalla sun315ketogenicdietunmaskingacaseofinsulinoma
AT ciancarellijames sun315ketogenicdietunmaskingacaseofinsulinoma
AT shapirolawrence sun315ketogenicdietunmaskingacaseofinsulinoma
AT klekstanislaw sun315ketogenicdietunmaskingacaseofinsulinoma